Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC
Onconetix, Inc. (NASDAQ: ONCO) announced an additional advance of $500,000 to Realbotix LLC, the target of its pending acquisition. This brings the total principal outstanding under the strategic bridge financing facility to $3,000,000, supporting the ongoing acquisition process.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.